- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GSK plc DRC (GSK)"GSK plc DRC stock price live, this page displays NYSE GSK stock exchange data. View the GSK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GSK plc DRC real time stock price chart below.
What Is the GSK plc DRC Stock Price Today?
The GSK plc DRC stock price today is 34.57.
What Is the Stock Symbol for GSK plc DRC?
The stock symbol for GSK plc DRC is ""GSK.""
What Stock Exchange Does GSK plc DRC Trade On?
GSK plc DRC is listed and trades on the NYSE stock exchange.
Is GSK plc DRC a Good Stock to Buy?
Determining whether GSK plc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GSK quote. (ISIN: US37733W2044)"
What Is the GSK plc DRC Stock Price Today?
The GSK plc DRC stock price today is 34.57.
What Is the Stock Symbol for GSK plc DRC?
The stock symbol for GSK plc DRC is ""GSK.""
What Stock Exchange Does GSK plc DRC Trade On?
GSK plc DRC is listed and trades on the NYSE stock exchange.
Is GSK plc DRC a Good Stock to Buy?
Determining whether GSK plc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GSK quote. (ISIN: US37733W2044)"
34.57
+0.04(+0.12%)
Closed
After Hours
34.72+0.15(+0.43%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.43
34.80
52 wk Range
32.83
45.93
GSK Scorecard
Full Analysis
High shareholder yield
High dividend Yield
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.4334.80
52 wk Range
32.8345.93
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(4.41%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(4.41%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockGSK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
45.23
Upside
+30.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
- HUTCHMED appoints new independent director
- Investing.com
- Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Japan expands RSV vaccine approval for adults 50-59
- Investing.com
GSK plc DRC Company Profile
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson’s disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
Compare GSK to Peers and Sector
Metrics to compare | GSK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGSKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.8x | 15.8x | −0.6x | |
PEG Ratio | −0.37 | 0.14 | 0.00 | |
Price/Book | 3.9x | 1.9x | 2.6x | |
Price / LTM Sales | 1.8x | 2.5x | 3.2x | |
Upside (Analyst Target) | 27.3% | 21.3% | 44.6% | |
Fair Value Upside | Unlock | 12.2% | 7.3% | Unlock |
Analysts' Recommendations
3 Buy
3 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 45.23
(+30.84% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.617
Dividend Yield
4.41%
Industry Median 1.74%
Annualised payout
1.5262
Paid quarterly
5-Years Growth
-
Growth Streak
FAQ
What Is the GSK plc DRC (GSK) Stock Price Today?
The GSK plc DRC stock price today is 34.57
What Stock Exchange Does GSK plc DRC Trade On?
GSK plc DRC is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for GSK plc DRC?
The stock symbol for GSK plc DRC is "GSK."
Does GSK plc DRC Pay Dividends? What’s The Current Dividend Yield?
The GSK plc DRC dividend yield is 4.41%.
What Is the GSK plc DRC Market Cap?
As of today, GSK plc DRC market cap is 69.88B.
What is GSK plc DRC Earnings Per Share?
The GSK plc DRC EPS is 0.617.
What Is the Next GSK plc DRC Earnings Date?
GSK plc DRC will release its next earnings report on 04 Feb 2025.
From a Technical Analysis Perspective, Is GSK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.